Business Context and Reporting Period
This Form 8-K Current Report was filed by Assembly Biosciences, Inc. on April 30, 2019, regarding events occurring on that date. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market under the symbol ASMB.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance data.
Material Changes
- Executive Departure: Graham Cooper resigned effective immediately on April 30, 2019, from all positions including Chief Operating Officer, Chief Financial Officer, principal operating officer, principal financial officer, and principal accounting officer.
- Interim Leadership: Effective May 1, 2019, Derek A. Small (CEO and President) assumed the role of principal financial officer with no additional compensation.
- Accounting Officer Appointment: Effective May 1, 2019, Michael P. Samar (VP, Finance and Business Operations) was appointed as principal accounting officer.
- Search Initiated: The company has initiated a search for a new Chief Financial Officer to replace Mr. Cooper.
- New Appointment: David J. Houck, Ph.D., was added as Senior Vice President, Product Development and Portfolio Management (detailed in the accompanying press release).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, or specific risk factors. The primary contingency noted is the immediate departure of the CFO and the interim nature of the financial leadership until a permanent replacement is found.
Investor Verification Checklist
- Confirm the timeline for the search and appointment of a permanent Chief Financial Officer.
- Review the press release (Exhibit 99.1) for details on David J. Houck's background and the strategic rationale for his appointment.
- Verify if the departure of Mr. Cooper impacts the company's ability to meet upcoming financial reporting deadlines.
- Check subsequent filings for any changes in the company's financial strategy or operational focus following the leadership transition.